NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically
Despite the great advances in medicine, mortality from cardiovascular diseases keeps on growing. This tendency is not likely to change considering the pandemic proportions of obesity and diabetes. Besides, the global population is more aged as life expectancy increases, and vascular aging plays a ke...
Saved in:
Main Authors: | Ainara González-Moro (Author), Inés Valencia (Author), Licia Shamoon (Author), Carlos Félix Sánchez-Ferrer (Author), Concepción Peiró (Author), Fernando de la Cuesta (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heroes and Villains
by: David R. Marples
Published: (2007) -
Pharmacological intervention of curcumin via the NLRP3 inflammasome in ischemic stroke
by: Xiaoxue Du, et al.
Published: (2023) -
Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer's Disease
by: Francesca La Rosa, et al.
Published: (2021) -
Targeting Oxidative Stress, NLRP3 Inflammasome, and Autophagy by Fraxetin to Combat Doxorubicin-Induced Cardiotoxicity
by: Ahmed M. Kabel, et al.
Published: (2021) -
NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation
by: Wang Z, et al.
Published: (2022)